Biocon.com
| Top biocon sites |
- Title
- Biocon - Biocon is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is committed to reduce therapy costs of chronic diseases like autoimmune, diabetes and cancer. Through innovative products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. As an emerging global biopharmaceutical enterprise it has developed and taken a range of novel biologics, biosimilars, differentiated small molecules and affordable recombinant human insulin and analogs from 'Lab to Market'. Some of its key brands are INSUGEN®(rh-insulin), BASALOG® (Glargine), CANMAb™ (Trastuzumab), BIOMAb-EGFR™(Nimotuzumab) and ALZUMAb ™(Itolizumab), a 'first in class' anti-CD6 monoclonal antibody. It has a rich pipeline of biosimilars and novel biologics at various stages of clinical development including a high potential oral insulin.
- Meta Description
- Biocon is an innovation led fully integrated biopharmaceutical company that has developed affordable biosimilars, novel biologics and complex APIs. Leader in fermentation based biopharmaceuticals. Global scale manufacturing set up for biologics, biosimilars. High end scientific talent, research and development infrastructure. Largest Indian insulins company. Rich pipeline of biosimilars with nine products and novel biologics at various stages of clinical development including a high potential oral insulin. Novel Biologics, Biosimilars, Fermentation based APIs, statins, Tacrolimus, Sirolimus, Everolimus, Human Insulin, Glargine, Immunosuppresants, Monoclonal Antibody, Recombinant Proteins, Generic formulations, Trastuzumab, Itolizumab, Nimotuzamab, BioMab EGFR, Biopharmaceutical, Biotechnology Company, EGFR, GCSF, Fermentation, Orlistat, Insulin Lispro, Peptides, Insulin Aspart, diabetes, cancer, oncology, autoimmune, breast cancer, head neck cancer, psoriasis, chronic disease
- Meta Keywords
- Biocon pharmaceuticals, biocon biosimilars, biocon fermentation, biocon human insulin, biocon oral insulin, biocon immunosuppresants, biocon monoclonal antibody, biocon recombinant proteins, biocon egfr, biocon gcsf, biocon immunosuppresants, biocon orlistat, biocon glargine, biocon peptides, Aspart, Biosimilars, EGFR, Fermentation, GCSF, Glargine, Human Insulin, Immunosuppresants, Lispro, Monoclonal Antibody, Orlistat, Oral Insulin, Peptides, Pharmaceutical Contract Manufacturing, Recombinant Proteins, Biotech, APIs, Formulations, Injectable, Discovery, Novel Molecules, Integrated Branded Formulations divisions are diabetology, oncology, nephrology, cardiology, comprehensive care, immunotherapy, Bioproducts, Research Services, Branded Formulations, Biosimilars, Small Molecules